COVID-19 Management Protocol

Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing global threat that is associated with high risks of infection, morbidities, and mortalities. The majority of patients with severe COVID-19 disease often present with acute respiratory distress syndrome (ARDS). ARDS associated with COVID-19 represents viral pneumonia with two processes, which includes viral pneumonia that eventually leads to ARDS [1]. Patients who develop ARDS present with worsening respiratory symptoms, hypoxemia, and bilateral lungs diseases, which eventually may result in cardiac failure. The prevalence of ARDS in COVID-19 patients is high, accounting for up to 42% of the patients [1]. Up to 61-81% of the patients who develop ARDS require intensive care [1]. This article will describe evidence-based approaches that have been used for the management of ARDS in critically ill patients with COVID-19